Our top pick for
HMS Holdings Corp is a health information services business based in the US. HMS shares (HMSY) are listed on the NASDAQ and all prices are listed in US Dollars. HMS employs 3,100 staff and has a trailing 12-month revenue of around USD$642.7 million.
|Latest market close||USD$33.78|
|52-week range||USD$18.195 - USD$36.87|
|50-day moving average||USD$31.8288|
|200-day moving average||USD$29.8469|
|Wall St. target price||USD$36.4|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.626|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-7.68%|
|1 month (2020-12-15)||3.30%|
|3 months (2020-10-15)||18.57%|
|6 months (2020-07-15)||2.61%|
|1 year (2020-01-15)||15.33%|
|2 years (2019-01-15)||17.74%|
|3 years (2018-01-12)||89.46%|
|5 years (2016-01-15)||188.96%|
Valuing HMS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HMS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HMS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 58x. In other words, HMS shares trade at around 58x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
HMS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2724. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into HMS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
HMS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$118.2 million.
The EBITDA is a measure of a HMS's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$642.7 million|
|Operating margin TTM||12.3%|
|Gross profit TTM||USD$234.7 million|
|Return on assets TTM||3.96%|
|Return on equity TTM||6.26%|
|Market capitalisation||USD$3.2 billion|
TTM: trailing 12 months
There are currently 1.2 million HMS shares held short by investors – that's known as HMS's "short interest". This figure is 10.5% down from 1.4 million last month.
There are a few different ways that this level of interest in shorting HMS shares can be evaluated.
HMS's "short interest ratio" (SIR) is the quantity of HMS shares currently shorted divided by the average quantity of HMS shares traded daily (recently around 371150.30487805). HMS's SIR currently stands at 3.28. In other words for every 100,000 HMS shares traded daily on the market, roughly 3280 shares are currently held short.
However HMS's short interest can also be evaluated against the total number of HMS shares, or, against the total number of tradable HMS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HMS's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 HMS shares in existence, roughly 10 shares are currently held short) or 0.0189% of the tradable shares (for every 100,000 tradable HMS shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against HMS.
Find out more about how you can short HMS stock.
We're not expecting HMS to pay a dividend over the next 12 months.
HMS's shares were split on a 3:1 basis on 17 August 2011. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your HMS shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for HMS shares which in turn could have impacted HMS's share price.
Over the last 12 months, HMS's shares have ranged in value from as little as $18.195 up to $36.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HMS's is 0.7769. This would suggest that HMS's shares are less volatile than average (for this exchange).
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions. It serves state Medicaid programs, commercial health plans, federal government health agencies, government and private employers, children's health insurance program, and other healthcare payers, as well as a subcontractor. The company was founded in 1974 and is headquartered in Irving, Texas.
Everything we know about the Home Point Capital Inc IPO, plus information on how to buy in.
Everything we know about the ALFI INC IPO, plus information on how to buy in.
Steps to owning and managing CDAY, with 24-hour and historical pricing before you buy.
Steps to owning and managing CPF, with 24-hour and historical pricing before you buy.
Steps to owning and managing CFFI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BPY, with 24-hour and historical pricing before you buy.
Steps to owning and managing BANF, with 24-hour and historical pricing before you buy.
Steps to owning and managing AVDL, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing AUDC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.